TrialCancer immunology, immunotherapy : CII2023

Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.

Alexandra M Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.